このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

adesso 将来の成長

Future 基準チェック /46

adesso利益と収益がそれぞれ年間37.7%と11.9%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に15.1% 37.8%なると予測されています。

主要情報

37.7%

収益成長率

37.8%

EPS成長率

IT 収益成長	16.2%
収益成長率	11.9%
将来の株主資本利益率	15.1%
アナリストカバレッジ	Low
最終更新日	17 May 2024

今後の成長に関する最新情報

Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results

Mar 28

Recent updates

adesso's (ETR:ADN1) Shareholders Will Receive A Bigger Dividend Than Last Year

May 21

adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.70

Apr 19

Returns On Capital Signal Tricky Times Ahead For adesso (ETR:ADN1)

Apr 18

Investors Can Find Comfort In adesso's (ETR:ADN1) Earnings Quality

Apr 02

Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results

Mar 28

業績と収益の成長予測

XTRA:ADN1 - アナリストの将来予測と過去の財務データ ( )EUR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	1,665	49	33	95	3
12/31/2025	1,465	38	24	85	4
12/31/2024	1,300	25	22	76	4
3/31/2024	1,182	-2	51	83	N/A
12/31/2023	1,140	3	43	77	N/A
9/30/2023	1,084	5	-23	7	N/A
6/30/2023	1,037	12	-28	-1	N/A
3/31/2023	969	18	7	35	N/A
12/31/2022	901	29	12	36	N/A
9/30/2022	836	29	12	36	N/A
6/30/2022	769	28	12	33	N/A
3/31/2022	725	37	17	36	N/A
12/31/2021	678	48	30	48	N/A
9/30/2021	636	45	23	43	N/A
6/30/2021	600	46	23	37	N/A
3/31/2021	564	42	34	47	N/A
12/31/2020	524	21	54	65	N/A
9/30/2020	503	24	34	40	N/A
6/30/2020	484	19	34	43	N/A
3/31/2020	467	18	22	33	N/A
12/31/2019	451	17	11	22	N/A
9/30/2019	432	15	1	13	N/A
6/30/2019	412	13	-9	3	N/A
3/31/2019	395	13	0	10	N/A
12/31/2018	378	14	9	18	N/A
9/30/2018	364	14	14	22	N/A
6/30/2018	351	14	20	26	N/A
3/31/2018	336	13	17	23	N/A
12/31/2017	322	11	N/A	20	N/A
9/30/2017	307	11	N/A	17	N/A
6/30/2017	292	11	N/A	13	N/A
3/31/2017	276	12	N/A	14	N/A
12/31/2016	261	12	N/A	15	N/A
9/30/2016	245	10	N/A	14	N/A
6/30/2016	229	7	N/A	14	N/A
3/31/2016	213	6	N/A	15	N/A
12/31/2015	197	5	N/A	17	N/A
9/30/2015	183	4	N/A	17	N/A
6/30/2015	169	4	N/A	16	N/A
3/31/2015	163	4	N/A	13	N/A
12/31/2014	157	3	N/A	9	N/A
9/30/2014	151	3	N/A	7	N/A
6/30/2014	145	2	N/A	5	N/A
3/31/2014	140	3	N/A	7	N/A
12/31/2013	135	3	N/A	8	N/A
9/30/2013	132	4	N/A	6	N/A
6/30/2013	129	4	N/A	4	N/A

アナリストによる今後の成長予測

収入対貯蓄率: ADN1は今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 0.7% ) よりも高い成長率であると考えられます。

収益対市場: ADN1今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: ADN1今後 3 年以内に収益を上げることが予想されます。

収益対市場: ADN1の収益 ( 11.9% ) German市場 ( 5.2% ) よりも速いペースで成長すると予測されています。

高い収益成長: ADN1の収益 ( 11.9% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: ADN1の自己資本利益率は、3年後には低くなると予測されています ( 15.1 %)。

adesso 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Consensus EPS estimates fall by 13%

Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results

Consensus EPS estimates fall by 63%, revenue upgraded

Consensus EPS estimates fall by 61%

Consensus EPS estimates fall by 19%

Consensus EPS estimates fall by 14%, revenue upgraded

Recent updates

Upcoming dividend of €0.70 per share

New major risk - Financial position

adesso's (ETR:ADN1) Shareholders Will Receive A Bigger Dividend Than Last Year

New major risk - Financial position

adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.70

Returns On Capital Signal Tricky Times Ahead For adesso (ETR:ADN1)

Investors Can Find Comfort In adesso's (ETR:ADN1) Earnings Quality

Consensus EPS estimates fall by 13%

Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results

Full year 2023 earnings: EPS misses analyst expectations

Is adesso SE (ETR:ADN1) Trading At A 44% Discount?

adesso SE (ETR:ADN1) Soars 29% But It's A Story Of Risk Vs Reward

Consensus EPS estimates fall by 63%, revenue upgraded

Dividend increased to €0.70

A Look At The Intrinsic Value Of adesso SE (ETR:ADN1)

Consensus EPS estimates fall by 61%

adesso SE to Report Fiscal Year 2023 Results on Mar 25, 2024

adesso SE to Report Q3, 2024 Results on Nov 14, 2024

Third quarter 2023 earnings released: EPS: €0.85 (vs €2.01 in 3Q 2022)

New minor risk - Earnings quality

Consensus EPS estimates fall by 19%

Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?

adesso SE Announces CEO Changes

Consensus EPS estimates fall by 14%, revenue upgraded

Second quarter 2023 earnings released: €1.18 loss per share (vs €0.29 loss in 2Q 2022)

Now 22% undervalued after recent price drop

At €106, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?

Now 20% undervalued after recent price drop

adesso SE Announces Board Changes

Calculating The Intrinsic Value Of adesso SE (ETR:ADN1)

Now 21% undervalued after recent price drop

Upcoming dividend of €0.65 per share at 0.5% yield

First quarter 2023 earnings released: EPS: €0.28 (vs €1.92 in 1Q 2022)

Consensus EPS estimates fall by 10%, revenue upgraded

adesso's (ETR:ADN1) Returns On Capital Not Reflecting Well On The Business

Now 24% undervalued after recent price drop

What Does adesso SE's (ETR:ADN1) Share Price Indicate?

Now 21% undervalued after recent price drop

adesso SE (XTRA:ADN1) signed an agreement to acquire 51% stake in Wepex GmbH.

adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet

Returns On Capital At adesso (ETR:ADN1) Have Stalled

adesso SE (XTRA:ADN1) acquired WebScience Srl.

Calculating The Fair Value Of adesso SE (ETR:ADN1)

At €138, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?

adesso SE to Report Q1, 2023 Results on May 15, 2023

Third quarter 2022 earnings released: EPS: €2.01 (vs €1.86 in 3Q 2021)

We Think adesso (ETR:ADN1) Can Stay On Top Of Its Debt

Price target decreased to €208

Second quarter 2022 earnings released: €0.29 loss per share (vs €1.12 profit in 2Q 2021)

adesso SE Revises Earnings Guidance for the Full Year 2022

Why adesso SE (ETR:ADN1) Could Be Worth Watching

adesso SE Revises Earnings Guidance for the Full Year 2022

adesso SE (XTRA:ADN1) acquired Quadox Ag.

adesso (ETR:ADN1) Hasn't Managed To Accelerate Its Returns

adesso SE (XTRA:ADN1) acquired remaining 41% stake in com2m GmbH.

Investor sentiment deteriorated over the past week

Now 22% undervalued after recent price drop

Upcoming dividend of €0.60 per share

First quarter 2022 earnings: EPS exceeds analyst expectations

Is adesso (ETR:ADN1) A Risky Investment?

Now 22% undervalued after recent price drop

Is It Too Late To Consider Buying adesso SE (ETR:ADN1)?

adesso (ETR:ADN1) Might Be Having Difficulty Using Its Capital Effectively

adesso SE (XTRA:ADN1) acquired Purple Scout AB from Johan Strömhage and Helena Bendz and others.

Now 23% undervalued after recent price drop

Full year 2021 earnings: EPS exceeds analyst expectations

Should You Be Adding adesso (ETR:ADN1) To Your Watchlist Today?

Now 21% undervalued

adesso SE acquired additional 23.4% minority stake in Material.One AG.